Bailey, T C <br/><br/>
Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxis.  [electronic resource] 

 -  American journal of kidney diseases : the official journal of the National Kidney Foundation  Feb 1993 
 - 196-201 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0272-6386 
<br/><br/><label>Standard No.: </label>10.1016/s0272-6386(12)81093-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antilymphocyte Serum--therapeutic use<br/>Cadaver<br/>Cohort Studies<br/>Cytomegalovirus Infections--epidemiology<br/>Female<br/>Graft Rejection--prevention & control<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Incidence<br/>Kidney Transplantation--immunology<br/>Male<br/>Multivariate Analysis<br/>Muromonab-CD3--therapeutic use<br/>Prospective Studies<br/>Risk Factors